Manufacturer
538 recalls in our database name Aidapak Services, LLC as the manufacturing or recalling firm.
Of the 538 recalls from Aidapak Services, LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 127 (24%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Aidapak Services, LLC is recalling 1,300 tablets of Glycopyrrolate 2 mg because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Triamterene/Hydrochlorothiazide tablets because they may have been mislabeled as Sevelamer HCl.
Aidapak Services, LLC is recalling Fenofibrate 54 mg tablets that may have been mislabeled as Famciclovir 500 mg.
Aidapak Services is recalling Cilostazol 100 mg tablets due to a potential label mixup with Calcium Acetate capsules. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Fluvastatin Sodium 20 mg capsules because they may be mislabeled as Valsartan 80 mg tablets.
Aidapak Services, LLC is recalling Phenol Lozenges because they may have been mislabeled as Atorvastatin Calcium or Vitamin B Complex W/C tablets.
Aidapak Services, LLC is recalling Flecaainide Acetate tablets because they may be mislabeled as Colestipol HCL Micronized.
Aidapak Services, LLC is recalling Methocarbamol 500 mg tablets because they may have been mislabeled as Losartan Potassium 25 mg.
Aidapak Services, LLC is recalling specific lots of Fenofibrate 54 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Levothyroxine Sodium tablets that may have been mislabeled as Multivitamin/Multimineral tablets.
Aidapak Services, LLC is recalling 403 tablets of Pyridoxine HCL 50 mg because they may have been mislabeled as other medications. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Aidapak Services is recalling Pancrelipase DR capsules because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Pregabalin 25 mg capsules because they may have been mislabeled as Cholecalciferol or Glyburide.
Aidapak Services is recalling 150 mg Irbesartan tablets because they may have been mislabeled as Benazepril HCl 40 mg.
Aidapak Services is recalling 50 mcg selenium tablets that may be mislabeled as guaifenesin ER 600 mg.
Aidapak Services, LLC is recalling Misoprostol 200 mcg tablets because they may be mislabeled as Propranolol HCl or Sodium Chloride.
Aidapak Services, LLC is recalling 25 mg Tramadol HCl tablets that may be mislabeled as Levothyroxine Sodium 137 mcg.
Aidapak Services, LLC is recalling Cholecalciferol/Calcium/Phosphorus tablets because they may be mislabeled as Promethazine HCl or Valsartan.
Aidapak Services is recalling Mirtazapine 7.5 mg tablets that may be mislabeled as Isoniazid 300 mg. The error poses a risk of incorrect medication administration.
Aidapak Services is recalling 1,998 docusate sodium capsules that may be mislabeled as 250 mg or tizanidine HCl tablets.
Aidapak Services is recalling 2,299 Propranolol HCL 10 mg tablets due to potential mislabeling as other medications.
Aidapak Services is recalling Nifedipine 10 mg capsules because they may be mislabeled as Nitrofurantoin 100 mg. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling FIDAXOMICIN 200 mg tablets that may be mislabeled as BENAZEPRIL HCL 40 mg. The error affects repacked drugs distributed in four western states.
Aidapak Services, LLC is recalling 10 mg Citalopram tablets because they may be mislabeled as Oxybutynin Chloride or Coenzyme Q-10.
Aidapak Services is recalling Pimozide 2 mg tablets because they may be mislabeled as Duloxetine HCl 20 mg capsules.